छोड़कर सामग्री पर जाएँ

Zydus Lifesciences hits 52-week high on USFDA approval for osteoporosis drug

  • द्वारा
  • Latest News

Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of $1.9 million in the United States.

Read More

​ Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of $1.9 million in the United States. Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of $1.9 million in the United States.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी